Comments
Loading...
Valeo Pharma Analyst Ratings and Price Targets | OTC:VPHIF | Benzinga
Valeo Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Valeo Pharma Corp from these most-recent analyst ratings.
Analyst Ratings for Valeo Pharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Valeo Pharma (VPHIF) stock?
There is no price target for Valeo Pharma
What is the most recent analyst rating for Valeo Pharma (VPHIF)?
There is no analyst for Valeo Pharma
When was the last upgrade for Valeo Pharma (VPHIF)?
There is no last upgrade for Valeo Pharma
When was the last downgrade for Valeo Pharma (VPHIF)?
There is no last downgrade for Valeo Pharma.
When is the next analyst rating going to be posted or updated for Valeo Pharma (VPHIF)?
There is no next analyst rating for Valeo Pharma.
Is the Analyst Rating Valeo Pharma (VPHIF) correct?
There is no next analyst rating for Valeo Pharma.
Browse analyst ratings and price targets on all stocks.
